Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Idiopathic sclerosing cholangitis. Pathophysiologic observations.

H O Douglass

    American Journal of Surgery
    |July 11, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Is glucagonoma of the pancreas a curable disease?

    International journal of pancreatology : official journal of the International Association of Pancreatology·2002
    Same author

    Unexpected cyanosis in the surgical patient.

    Surgical endoscopy·2001
    Same author

    A patient's right to truly informed consent.

    Archives of surgery (Chicago, Ill. : 1960)·2000
    Same author

    Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.

    Annals of surgical oncology·2000
    Same author

    Results from National Surgical Adjuvant Breast and Bowel project colon cancer trials.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
    Same author

    Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.

    International journal of radiation oncology, biology, physics·1998

    Idiopathic sclerosing cholangitis treatment improved with steroids, which reduced liver inflammation and biliary stenosis. Steroids were crucial for clinical recovery, including weight gain and reduced portal pressure.

    Area of Science:

    • Hepatology
    • Gastroenterology
    • Radiology

    Background:

    • Idiopathic sclerosing cholangitis (ISC) is a chronic liver disease characterized by bile duct inflammation and fibrosis.
    • Portal hypertension is a known complication of advanced liver disease, including ISC.
    • Pruritus, jaundice, and weight loss are common clinical manifestations of ISC.

    Purpose of the Study:

    • To investigate the hemodynamic and structural changes in a patient with idiopathic sclerosing cholangitis.
    • To evaluate the efficacy of T-tube drainage and steroid therapy in managing ISC.
    • To correlate imaging findings with clinical outcomes and histopathological changes.

    Main Methods:

    • Selective hepatic arteriography and umbilical portography were performed to assess liver blood flow.

    Related Experiment Videos

  • T-tube cholangiography was used to visualize the biliary tree.
  • Clinical parameters, including pruritus, jaundice, weight, and portal pressure, were monitored.
  • Liver biopsy was performed before and after treatment for histopathological analysis.

    • Main Results:

    • Arteriography and portography showed uneven liver blood flow and mild portal hypertension.
    • T-tube drainage provided symptomatic relief from pruritus.
    • Steroid therapy led to significant clinical improvement, including weight gain, resolution of jaundice, and reduced portal pressure.
    • Liver biopsy after one year of steroid therapy demonstrated reduced periportal inflammation and biliary stenosis.

    Conclusions:

    • Steroid therapy is effective in managing idiopathic sclerosing cholangitis, improving both clinical symptoms and histopathological findings.
    • Hemodynamic alterations, such as uneven liver blood flow and portal hypertension, are associated with ISC.
    • A multidisciplinary approach combining interventional procedures and pharmacotherapy is essential for optimal patient outcomes in ISC.